OPCICON ONE-STEP Drug Patent Profile
✉ Email this page to a colleague
When do Opcicon One-step patents expire, and when can generic versions of Opcicon One-step launch?
Opcicon One-step is a drug marketed by Sun Pharm and is included in one NDA.
The generic ingredient in OPCICON ONE-STEP is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Opcicon One-step
A generic version of OPCICON ONE-STEP was approved as levonorgestrel by NOVEL LABS INC on February 22nd, 2013.
Summary for OPCICON ONE-STEP
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for OPCICON ONE-STEP |
DailyMed Link: | OPCICON ONE-STEP at DailyMed |
Pharmacology for OPCICON ONE-STEP
Drug Class | Progestin Progestin-containing Intrauterine Device Progestin-containing Intrauterine System |
Physiological Effect | Inhibit Ovum Fertilization |
Anatomical Therapeutic Chemical (ATC) Classes for OPCICON ONE-STEP
US Patents and Regulatory Information for OPCICON ONE-STEP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm | OPCICON ONE-STEP | levonorgestrel | TABLET;ORAL | 202635-001 | Sep 11, 2014 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |